• 1
    Fine JD, Eady RA, Bauer EA et al. The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008; 58:93150.
  • 2
    Hilal L, Rochat A, Duquesnoy P et al. A homozygous insertion–deletion in the type VII collagen gene (COL7A1) in Hallopeau–Siemens dystrophic epidermolysis bullosa. Nat Genet 1993; 5:28793.
  • 3
    Stanley JR, Rubinstein N, Klaus-Kovtun V. Epidermolysis bullosa acquisita antigen is synthesized by both human keratinocytes and human dermal fibroblasts. J Invest Dermatol 1985; 85:5425.
  • 4
    Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol 2009; 61:36784.
  • 5
    Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. J Am Acad Dermatol 2009; 61:387402.
  • 6
    Bruckner-Tuderman L, McGrath JA, Robinson EC et al. Progress in epidermolysis bullosa research: summary of DEBRA International Research Conference 2012. J Invest Dermatol 2013; 133:21216.
  • 7
    Wong T, Gammon L, Liu L et al. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2008; 128:217989.
  • 8
    El Ghalbzouri A, Ponec M. Diffusible factors released by fibroblasts support epidermal morphogenesis and deposition of basement membrane components. Wound Repair Regen 2004; 12:35967.
  • 9
    Ortiz-Urda S, Lin Q, Green CL et al. Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. J Clin Invest 2003; 111:2515.
  • 10
    Woodley DT, Krueger GG, Jorgensen CM et al. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. J Invest Dermatol 2003; 121:10218.
  • 11
    Nagy N, Almaani N, Tanaka A et al. HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa. J Invest Dermatol 2011; 131:17714.
  • 12
    European Medicines Agency. Committee for Medicinal Products for Human Use. Guidelines on Clinical Trials in Small Populations. CHMP/EWP/83561/2005. London: EMA, 2006. Available at: (last accessed 27 September 2013).
  • 13
    Venugopal SS, Yan H, Tran K et al. Investigation of cell therapy for generalized severe recessive dystrophic epidermolysis bullosa by intradermal allogeneic fibroblasts randomized against placebo injections. Australas J Dermatol 2009; 50: A56 [abstr].
  • 14
    Kirsner RS, Marston WA, Snyder RJ et al. Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2012; 380:97785.
  • 15
    McGrath JA, Schofield OM, Ishida-Yamamoto A et al. Cultured keratinocyte allografts and wound healing in severe recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol 1993; 29:40719.
  • 16
    Falabella AF, Valencia IC, Eaglstein WH et al. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol 2000; 136:122530.
  • 17
    Fivenson DP, Scherschun L, Choucair M et al. Graftskin therapy in epidermolysis bullosa. J Am Acad Dermatol 2003; 48:88692.
  • 18
    Natsuga K, Sawamura D, Goto M et al. Response of intractable skin ulcers in recessive dystrophic epidermolysis bullosa patients to an allogeneic cultured dermal substitute. Acta Derm Venereol 2010; 90:1659.
  • 19
    Conget P, Rodriguez F, Kramer S et al. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy 2010; 12:42931.
  • 20
    Wagner JE, Ishida-Yamamoto A, McGrath JA et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 2010; 363:62939.